封面
市场调查报告书
商品编码
1674133

睡眠辅助市场(依产品类型、睡眠障碍和地区划分)

Sleep Aids Market, By Product Type, By Sleep Disorder, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 187 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球睡眠辅助市场规模将达到 837.5 亿美元,到 2032 年将达到 1,417.7 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 7.8%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 837.5亿美元
效能资料 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 7.80% 2032年价值预测 1417.7亿美元
数字。 2025年睡眠辅助市场占有率(%)
助眠产品市场-IMG1

由于睡眠障碍的日益普遍,全球睡眠辅助市场在过去几年中一直稳定成长。压力水平上升、生活方式改变和人口老化已成为失眠和其他睡眠障碍的主要因素。此外,人们越来越意识到睡眠不足对健康和生产力的负面影响,导致更多的人寻求治疗。为了帮助人们获得充足的休息,市场上充斥着各种各样的安眠药和设备。随着人们的健康意识不断增强,草药和补充剂等天然产品也因促进睡眠而越来越受欢迎。由于持续的研究和开发带来创新以及新兴国家需求的不断增长,预计未来几年睡眠辅助市场将进一步显着增长。

市场动态:

全球睡眠辅助市场受到睡眠障碍盛行率上升的推动,这主要是由于饮食习惯的改变、忙碌的生活方式和压力水平的增加。睡眠不足与许多健康问题有关,包括肥胖、心臟病和忧郁症,促使人们采用助眠剂。此外,老年人口的不断增长更容易受到睡眠障碍的影响,这也为该行业的公司带来了巨大的潜在市场。然而,处方安眠药的副作用和风险构成了重大挑战。此外,许多国家对替代疗法的偏好也在一定程度上阻碍了市场收益的成长。同时,包括穿戴式装置和行动应用在内的睡眠科技创新步伐正在提供新的机会。人们对失眠影响的认识不断提高以及新兴经济体医疗保健基础设施的改善将在未来几年进一步推动该行业的扩张。

本研究的主要特点

  • 本报告对全球睡眠辅助市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模(以十亿美元为单位)和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 全球睡眠辅助市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 主要企业有辉瑞公司、葛兰素史克公司、Sommetrics 公司、Cadwell Industries 公司、SleepMed 公司、Natus Medical Incorporated、Therapix Biosciences 有限公司、Compumedics 有限公司、Eisai公司、Tris Pharma 公司、阿诺华公司、Idorsia Pharmaceuticals 有限公司、Res 和阿斯诺华公司、Idorsia Pharmaceuticals 有限公司、Res 和阿斯特。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球睡眠辅助市场迎合了该行业的各种相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球睡眠辅助市场所使用的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 製造商收益
  • 收购与合作场景
  • 产品发布/核准
  • 资金筹措与投资
  • PEST分析
  • 波特的分析

4. 全球睡眠辅助市场-冠状病毒(COVID-19)大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020-2032 年全球助眠产品市场(按产品类型划分)(十亿美元)

  • 製药
  • 睡眠呼吸中止设备
  • 床垫和枕头
  • 其他的

6. 2020-2032 年全球睡眠辅助市场(以睡眠障碍划分)(十亿美元)

  • 失眠
  • 睡眠呼吸中止症
  • 不宁腿
  • 夜惊
  • 其他的

7. 2020-2032 年全球助眠产品市场(按地区划分)(单位:十亿美元)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章竞争格局

  • 公司简介
    • Pfizer Inc.
    • GSK plc
    • Sommetrics, Inc.
    • Cadwell Industries, Inc.
    • SleepMed, Inc.
    • Natus Medical Incorporated
    • Therapix Biosciences Ltd
    • Compumedics Limited
    • Eisai Co., Ltd.
    • Tris Pharma, Inc.
    • Novartis AG
    • Idorsia Pharmaceuticals Ltd.
    • ResMed
    • AstraZeneca

第九章 分析师观点

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1059

Global Sleep Aids Market is estimated to be valued at USD 83.75 Bn in 2025 and is expected to reach USD 141.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 83.75 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.80% 2032 Value Projection: USD 141.77 Bn
Figure. Sleep Aids Market Share (%), By Region 2025
Sleep Aids Market - IMG1

The global sleep aids market has been witnessing steady growth in the last few years owing to the increasing prevalence of sleep disorders. Rising stress levels, changing lifestyles, and growing aging population have emerged as major factors fueling insomnia and other sleep disorders. Moreover, growing awareness about the ill-effects of sleep deprivation on health and productivity are prompting a greater number of people to seek treatment. Various sleep medications and devices have flooded the market to help people get adequate rest. With growing health consciousness, more natural products like herbs and supplements are also gaining popularity for sleep promotion. The sleep aids market is expected to further grow at a notable rate in the coming years on the back of ongoing research and development leading to innovations as well as increasing demand from emerging countries.

Market Dynamics:

The global sleep aids market is driven by the rising prevalence of sleep disorders mainly due to changing dietary patterns, busy lifestyles, and increasing stress levels. Sleep deprivation is linked to numerous health issues like obesity, heart diseases, and depression which has boosted the adoption of sleep aids. The growing geriatric population which is more prone to sleep disorders also presents a large addressable market for industry players. However, side effects and risks associated with prescription sleep drugs pose a major challenge. Also, preference for alternative therapies in many countries hamper the market revenue growth to some extent. On the other hand, pace of innovation in sleep technology involving wearable devices and mobile apps offer new opportunities. Growing awareness about the consequences of insomnia and improving healthcare infrastructure in emerging nations will further support industry expansion going forward.

Key Features of the Study:

  • This report provides an in-depth analysis of the global sleep aids market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global sleep aids market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this Pfizer Inc., GSK plc, Sommetrics, Inc., Cadwell Industries, Inc., SleepMed, Inc., Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Idorsia Pharmaceuticals Ltd., ResMed, AstraZeneca.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global sleep aids market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sleep aids market.

Detailed Segmentation-

  • By Product Type:
    • Medications
    • Sleep Apnea Devices
    • Mattresses and Pillows
    • Others
  • By Sleep Disorder:
    • Insomnia
    • Sleep Apnea
    • Restless Legs Syndrome
    • Night Terrors
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Pfizer Inc.
    • GSK plc
    • Sommetrics, Inc.
    • Cadwell Industries, Inc.
    • SleepMed, Inc.
    • Natus Medical Incorporated
    • Therapix Biosciences Ltd
    • Compumedics Limited
    • Eisai Co., Ltd.
    • Tris Pharma, Inc.
    • Novartis AG
    • Idorsia Pharmaceuticals Ltd.
    • ResMed
    • AstraZeneca

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sleep Disorder
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Sleep Aids Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Sleep Aids Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Medications
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sleep Apnea Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mattresses and Pillows
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Sleep Aids Market, By Sleep Disorder 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Insomnia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sleep Apnea
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Restless Legs Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Night Terrors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Sleep Aids Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sommetrics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cadwell Industries, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SleepMed, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Natus Medical Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Therapix Biosciences Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Compumedics Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eisai Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Tris Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Idorsia Pharmaceuticals Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ResMed
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact